MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • cariou valerie

    France

  • CARLOS ROBERTO CABRAL

    DOHE FIGADO Associação dos Doentes e Transplantados Hepaticos do Estado do Rio de Janeiro

    Brazil

  • carole damien

    militante

    France

  • Carpentier Guillaume

    AIDS-Hilfe Potsdam e.V.

    Germany

  • Carreirão Luiz Fernando

    Ciasc

    Brazil

  • CARRERE Arnaud

    Actions-Traitements

    France

  • Carro Elorza Alvaro

    Spain

  • Carstensen Jens

    Germany

  • Caspar Fridtjof

    Germany

  • Castillo Jodra Concepcion

    Spain

  • Castro Lino Arturo

    Coordinadora de ONG de las Americas sobre el Sida Carcel y Encierro(COASCE) Secretaria Ejecutiva Colegiada para Centroamerica y el Caribe

    Dominican Republic

  • Castro Lino Arturo

    Fundación Red de Jóvenes Unidos de Guachupita(FURJUG)

    Dominican Republic

  • Catherine LEGUAY

    France

  • Catron Kelly

    Hepatitis C Global Initiatives

    United States

  • CAYRON jeff

    France

  • Cebrián Solbas Sonia

    Spain

  • Centelles Joan

    Spain

  • CHAFIK Belgacem

    Association de lutte contre le sida

    Morocco

  • Chakvetadze Natalia

    Step Forward

    Georgia

  • Chan Ma. Fernanda

    Asociación de Mujeres Gente Nueva -AMUGEN-

    Guatemala

  • Chang Kun

    AIBO AIDS Relief Law Network

    China

  • chapa ita

    personnel

    France

  • Chappaz Romain

    CIGaLes

    France

  • CHARNAY CHARNAY

    France

  • Charrier Yannick

    AIDeS

    France

  • Chaumény Olivier

    France

  • Chavat Patricio

    Spain

  • Chavchanidze Marina

    Pozitive Choise

    Georgia

  • Chavez Orlando

    Berkeley Free Clinic

    United States

  • Chavez Enrique

    AID FOR AIDS International

    United States

  • Chałupka Marcin

    Krytyka Polityczna

    Poland

  • Chehade Katia

    Hepatitis NSW

    Australia

  • Chene Ludovic

    Act Up-Paris

    France

  • Chernyshev Andrii

    PO "GAY-ALLIANCE"

    Ukraine

  • Cherry Bruce

    Hepatitis NSW

    Australia

  • Chettri Basanta

    HIV Volunteer Activist

    Nepal

  • chiguru Judith

    WAHABIMA NGO

    Tanzania

  • Childs Robert

    North Carolina Harm Reduction Coalition

    United States

  • Chinalieva Saltanat

    NBKR

    Kyrgyzstan

  • Chingsubam Bangkim

    SASO

    India

  • chiqovani natalia

    poliklinika zugdidi

    Georgia

  • CHIRETU GEORGE

    Romania

  • CHIVA RIPODAS HELENA

    Spain

  • Chkhubianishvili David

    independent expert, HCV survivor

    Georgia

  • Chokheli Marina

    Georgia

  • Chong Lenn

    Malaysia

  • Chongtham Kuleshwor

    BABINA Diagnostics, Imphal

    India

  • Chovancová Iveta

    ODYSEUS

    Slovakia

  • Christensen Rosanne

    Hepatitis C Support Project

    United States

  • Christiane PONS

    AIDES

    France